<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01484613</url>
  </required_header>
  <id_info>
    <org_study_id>H56</org_study_id>
    <nct_id>NCT01484613</nct_id>
  </id_info>
  <brief_title>Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads</brief_title>
  <acronym>EffaceQ</acronym>
  <official_title>Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients With Quadripolar LV Leads</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac resynchronization (CRT) therapy is well established for treatment of patients with
      severe heartfailure, reduced left ventricular (LV) function and ventricular dyssynchrony.
      Roughly 1/3 of CRT patients do not improve after CRT implant. One possible reason is
      interruption of biventricular pacing. This might be caused by several conditions, including
      elevated left ventricular (LV) pacing thresholds or presence of phrenic nerve stimulation
      (PNS). CRT devices with quadripolar LV leads offer 10 LV pacing vectors to choose from. It's
      the aim of this prospective observational study to investigate efficacy and reliability of
      cardiac resynchronization therapy (CRT) with quadripolar left ventricular leads.

      Hypothesis: In more than 90% of patients, who received a CRT system with quadripolar LV lead,
      at least one acceptable LV lead vector is available.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Definition of an acceptable lead vector: Any LV pacing vector that complies in both tested
      body positions (left lateral position and sitting) with both criteria:

        1. Phrenic nerve stimulation threshold is at least twice as high as LV pacing threshold

        2. LV pacing threshold is less or equals 2.5Volts (V) @0.5 milliseconds (ms)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with at least one acceptable lead vector</measure>
    <time_frame>Pre hospital discharge (PHD) to 3 months</time_frame>
    <description>Definition of acceptable lead vector:
Any LV vector that complies in both tested body positions with both criteria:
Phrenic nerve stimulation threshold is at least twice as high as LV pacing threshold
LV pacing threshold is less or equals 2.5V@0.5ms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Baseline to 3 months</time_frame>
    <description>Minnesota living with heart failure questionaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phrenic nerve stimulation (PNS)</measure>
    <time_frame>PHD to 3 months</time_frame>
    <description>Incidence of PNS per LV pacing vector
Freedom from PNS for the permanently programmed LV vector</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV pacing thresholds</measure>
    <time_frame>PHD to 3 months</time_frame>
    <description>LV pacing thresholds per LV vector
Incidence of elevated (&gt;2.5V/0.5ms) LV pacing thresholds per LV vector</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of acceptable LV lead vectors per patient</measure>
    <time_frame>PHD to 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Finally programmed LV lead vector</measure>
    <time_frame>PHD to 3 months</time_frame>
    <description>Need for reprogramming
Percentage of patients with conventional (bipolar) and extended (quadripolar) LV vectors</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">337</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Quadripolar lead</arm_group_label>
    <description>All participants receive a CRT-D system with quadripolar lead</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>quadripolar LV lead (Quartet)</intervention_name>
    <description>All participants will receive CRT-D system with a quadripolar lead. This lead offers 10 LV lead vectors to choose from</description>
    <arm_group_label>Quadripolar lead</arm_group_label>
    <other_name>Quartet</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are planned for being implanted with a cardiac resynchronization therapy
        implantable cardioverter defibrillator (CRT-D) system in the participating centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for implantation of a CRT-D

          -  Age &gt;= 18 years

          -  Written informed consent

        Exclusion Criteria:

          -  Already implanted LV or coronary sinus lead

          -  Previous unsuccessful LV lead implant attempt

          -  Patient is eligible for heart transplantation

          -  Comorbidities that results in life expectancy of less than 12 months

          -  Known pregnancy

          -  Inability to provide written patient informed consent

          -  Participation to another study with active treatment arm (i.e. randomized studies
             etc...)

          -  Patient is not willing or is not able to visit the study center for the study
             assessments within the first 3 months after implant

          -  Patient is not able to understand or answer the quality of life questionaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johannes Brachmann, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Coburg GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Coburg GmbH</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Mörsenbroich-Rath GmbH</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40472</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Esslingen</name>
      <address>
        <city>Esslingen</city>
        <zip>73730</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardioangiologisches Centrum Bethanien</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäßzentrum am Krankenhaus Neu-Bethlehem</name>
      <address>
        <city>Göttingen</city>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Kalk</name>
      <address>
        <city>Köln</city>
        <zip>51103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Stadt Ludwigshafen am Rhein gGmbH</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.-Marien-Hospital GmbH</name>
      <address>
        <city>Lünen</city>
        <zip>44534</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Magdeburg gGmbH</name>
      <address>
        <city>Magdeburg</city>
        <zip>39130</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marien-Hospital</name>
      <address>
        <city>Marl</city>
        <zip>45768</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Großhadern der Ludwig-Maximilians-Universität München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niels-Stensen-Kliniken Marienhospital Osnabrück</name>
      <address>
        <city>Osnabrück</city>
        <zip>49074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dorothea Christiane Erxleben GmbH</name>
      <address>
        <city>Quedlinburg</city>
        <zip>06484</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2011</study_first_submitted>
  <study_first_submitted_qc>December 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2011</study_first_posted>
  <last_update_submitted>November 21, 2014</last_update_submitted>
  <last_update_submitted_qc>November 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hear Failure</keyword>
  <keyword>Cardiac resynchronization</keyword>
  <keyword>CRT-D</keyword>
  <keyword>quadripolar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

